HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-term effects of indapamide in left ventricular hypertrophy in patients with hypertension].

Abstract
Left ventricular hypertrophy is a major and independent cardiovascular risk factor in hypertension. The effects of a diuretic, indapamide, on the regression of left ventricular hypertrophy were studied in a group of 9 patients with mild hypertension treated in an open therapeutic trial over a 12 month period. At the end of the trial, the left ventricular mass index decreased significantly from 172 +/- 11 to 147 +/- 11 g/m2 (p less than 0.001). Therefore, in contrast to the other diuretics which have been studied, indapamide seems able to induce regression of the left ventricular hypertrophy complicating hypertension.
AuthorsM Komajda, K Klimczak, J Evans, B Boutin, F Brackman, D Guez, Y Grosgogeat
JournalArchives des maladies du coeur et des vaisseaux (Arch Mal Coeur Vaiss) Vol. 83 Spec No 4 Pg. 45-50 (Dec 1990) ISSN: 0003-9683 [Print] France
Vernacular TitleEffets à long terme de l'indapamide sur l'hypertrophie ventriculaire gauche de l'hypertendu.
PMID2150474 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Indapamide
Topics
  • Adult
  • Aged
  • Cardiomegaly (drug therapy, etiology)
  • Drug Evaluation
  • Female
  • Humans
  • Hypertension (complications, drug therapy)
  • Indapamide (therapeutic use)
  • Male
  • Middle Aged
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: